Ophthalmic preoperative sterilization study of 1.5% LVFX ophthalmic solutio
Phase 4
- Conditions
- Ophthalmic preoperative sterilization
- Registration Number
- JPRN-jRCT1080221649
- Lead Sponsor
- SANTEN PHARMACEUTICAL CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
20 years or older at the time of acquisition of the informed consent
- those who are scheduled for cataract surgery
Exclusion Criteria
- those with a history of serious adverse reaction including hypersensitivity to fluoroquinolone
- those judged by the investigator to be otherwise inappropriate as subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Preoperative sterilization rate<br>Culture-negative conversion rate in the conjunctival sac by the preoperative instillation of 1.5% Levofloxacin ophthalmic solution
- Secondary Outcome Measures
Name Time Method postoperative non-bacterial rate<br>Culture-negative conversion rate in the conjunctival sac by the postoperative instillation of 1.5% Levofloxacin ophthalmic solution